J Appl Biomed 1:7-12, 2003 | DOI: 10.32725/jab.2003.002

Biologically active pentacyclic triterpenes and their current medicine signification

Jiří Patočka
Department of Toxicology, Military Medical Academy, Hradec Králové and Department of Radiology, Faculty of Health and Social Care, University of South Bohemia, České Budějovice, Czech Republic

Pentacyclic triterpenes are produced by arrangement of squalene epoxide. These compounds are extremely common and are found in most plants. There are at least 4000 known triterpenes. Many triterpenes occur freely but others occur as glycosides (saponins) or in special combined forms. Pentacyclic triterpenes have a wide spectrum of biological activities and some of them may be useful in medicine. The therapeutic potential of three pentacyclic triterpenes - lupeol, betuline and betulinic acid - is discussed in this paper. Betulinic acid especially is a very promising compound. This terpene seems to act by inducing apoptosis in cancer cells. Due to its apparent specificity for melanoma cells, betulinic acid seems to be a more promising anti-cancer substance than drugs like taxol.

Keywords: pentacyclic triterpene; lupeol; betuline; betulinic acid; biological activity

Published: March 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Patočka J. Biologically active pentacyclic triterpenes and their current medicine signification. J Appl Biomed. 2003;1(1):7-12. doi: 10.32725/jab.2003.002.
Download citation

References

  1. De Clercq E.: Novel compounds in preclinical/early clinical development for the treatment of HIV infections. Rev Med Virol 10:255-277. 2000; Erratum in: Rev Med Virol 10:349, 2000. Go to original source... Go to PubMed...
  2. Fernandez M.A., B. de las Heras, M.D.Garcia M.T.Saenz, A.Villar: New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. J Pharm Pharmacol 53:1533-1539, 2001. Go to original source... Go to PubMed...
  3. Fulda S., I. Jeremias, H.H.Steiner, T.Pietsch, K.M.Debatin: Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int J Cancer 82:435-441, 1999. Go to original source...
  4. Fulda S., S.A.Susin, G.Kroemer, K.M.Debatin: Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res 58:4453-4460, 1999.
  5. Geetha T., P. Varalaxmi: Anti-inflammatory activity of lupeol and lupeol linoleate in adjuvant-induced arthritis. Fitoterapia 69: 13-19, 1998.
  6. González-Coloma A., M. Reina, B.M.Frga, C.Gutiérrez, C.L.Balboa: Bioactive Lupeol from Senecio heritieri structure - activity relationship. Conference of the International Society of Chemical Ecology, Marseille 1999; Abstract p. 44.
  7. Hashimoto F., Y. Kashiwada, L.M.Cosentino, C.H.Chen, P.E.Garrett, K.H.Lee: Anti-AIDS agents - XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. Bioorg Med Chem 5:2133-2143, 1997. Go to original source... Go to PubMed...
  8. Huang C., H. Tunon, L. Bohlin: Anti-inflammatory compounds isolated from Menyanthes trifoliata L. Yao Xue Xue Bao 30:621-626, 1995. Go to PubMed...
  9. Kanamoto T., Y. Kashiwada, K. Kanbara, K. Gotoh, M. Yoshimori, T. Goto, K. Sano, H. Nakashima: Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob Agents Chemother 45:1225-1230, 2001. Go to original source... Go to PubMed...
  10. Kashiwada Y., J. Chiyo, Y. Ikeshiro, T. Nagao, H. Okabe, L.M.Cosentino, K.Fowke, S.L.Morris-Natschke, K.H.Lee: Synthesis and anti-HIV activity of 3-alkylamido-3-deoxy-betulinic acid derivatives. Chem Pharm Bull (Tokyo) 48:1387-1390, 2000. Go to original source... Go to PubMed...
  11. Kashiwada Y., F. Hashimoto, L.M.Cosentino, C.H.Chen, P.E.Garrett, K.H.Lee: Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J Med Chem 39:1016-1017, 1996. Go to original source... Go to PubMed...
  12. Kweifio-Okai G., F. de Munk., T.A. Macrides., P. Smith, B.A. Rumble: Anti-arthritic mechanisms of Lupeol Triterpenes. Drug Develop Research 36: 20-24, 1995. Go to original source...
  13. Ma C., N. Nakamura, H. Miyashiro, M. Hattori, K. Shimotohno: Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease. Chem Pharm Bull (Tokyo) 47:141-145, 1999. Go to original source... Go to PubMed...
  14. Min B.S., J.J.Gao, N.Nakamura, M.Hattori: Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull (Tokyo) 48:1026-1033, 2001. Go to original source...
  15. Nagumo A., K.Takanashi, H.Hojo, Y.Suzuki: Cytotoxicity of bacteriohopane-32-ol against mouse leukemia L1210 and P388 cells in vitro. Toxicol Lett 58:309-313, 2001. Go to original source...
  16. Najid A., A.Simon, J.Cook, H.Chable-Rabinovitch, C.Delage, A.J.Chulia, M.Rigaud: Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett 299:213-217, 1992. Go to original source... Go to PubMed...
  17. Novotny L., A. Vachalkova, D.Biggs: Ursolic acid: an anti-tumorigenic and chemopreventive activity. Neoplasma 48:241-246, 2001. Go to PubMed...
  18. Olukoga A., D. Donaldson: Liquorice and its health implications. J R Soc Health 120:83-89, 2000. Go to original source... Go to PubMed...
  19. Patočka J: Antiinflammatory triterpenoids from mysterious muscroom Ganoderma lucidum and their potential possibility in modern medicine. Acta Medica (Hradec Kralove) 42:123-125, 1999. Go to original source... Go to PubMed...
  20. Pisha E., H.Chai, I.S.Lee, T.E.Chagwedera, N.R.Farnsworth, G.A.Cordell, C.W.Beecher, H.H.Fong, A.D.Kinghorn, D.M.Brown et al.: Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1:1046-1051, 1995. Go to original source... Go to PubMed...
  21. Rajic A., G. Kweifio-Okai, T. Macrides, R.M.Sandeman, D.S.Chandler, G.M.Polya: Inhibition of serine proteases by anti-inflammatory triterpenoids. Planta Med 66:206-210, 2000. Go to original source... Go to PubMed...
  22. Recio M.C., R.M.Giner, S.Manez, J.L.Rios: Structural requirements for the anti-inflammatory activity of natural triterpenoids. Planta Med 61:182-185, 1995. Go to original source... Go to PubMed...
  23. Rieber M., M. Strasberg Rieber: Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma. DNA Cell Biol 17:399-406, 1998. Go to original source... Go to PubMed...
  24. Salti G.I., J.V.Kichina, T.K.Das Gupta, S. Uddin, L.Bratescu, J.M.Pezzuto, R.G.Mehta, A.I.Constantinou : Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent. Melanoma Res 11:99-104, 2001. Go to original source... Go to PubMed...
  25. Schmidt M.L., K.L.Kuzmanoff, L.Ling-Indeck, J.M.Pezzuto : Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur J Cancer 33:2007-2010, 1997. Go to original source...
  26. Selzer E., E. Pimentel, V. Wacheck, W.Schlegel, H.Pehamberger, B.Jansen, R.Kodym: Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol 114:935-940, 2000. Go to original source... Go to PubMed...
  27. Simoes C.M., M.Amoros, L.Girre: Mechanism of antiviral activity of triterpenoid saponins. Phytother Res 13:323-328, 1999. Go to original source...
  28. Singh G.B., S.Singh, S.Bani, B.D.Gupta, S.K.Banerjee: Anti-inflammatory activity of oleanolic acid in rats and mice. J Pharm Pharmacol 44:456-458, 1992. Go to original source... Go to PubMed...
  29. Sirtori C.R. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res 44:183-193, 2001. Go to original source... Go to PubMed...
  30. Soler F., C. Poujade, M. Evers, J. C. Carry, Y.Henin, A.Bousseau, T. Huet, R.Pauwels, E. De Clercq, J.F.Mayaux, J.B. Le Pecq, N. Dereu: Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J Med Chem 39:1069-1083, 1996. Go to original source... Go to PubMed...
  31. Subhadhirasakul S., H.Takayama, F.M.Kitajima, N.F.Aimi: Triterpenoids from Thai medicinal plant, Willughbeia firma. Natural Med 54: 155-157, 2000.
  32. Szakiel A., I.Wasiukiewicz, W.Janiszowska: Metabolism of [3-3H]oleanolic acid in the isolated Calendula officinalis leaf cells and transport of the synthesized glycosides to the cell wall and the extracellular space. Acta Biochim Pol 42:25-29, 1995. Go to original source... Go to PubMed...
  33. Takeoka G., L. Dao, R. Teranishi, R.Wong, S.Flessa, L.Harden, R.Edwards: Identification of three triterpenoids in almond hulls. J Agric Food Chem 48:3437-3439, 2000. Go to original source... Go to PubMed...
  34. Zuco V., R. Supino, S.C.Righetti, L.Cleris, E.Marchesi, C.Gambacorti-Passerini, F.Formelli: Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 175:17-25, 2002. Go to original source... Go to PubMed...